For the quarter ending 2026-03-31, UPB made $1,034K in revenue. -$40,591K in net income. Net profit margin of -3925.63%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Collaboration revenue | 1,034 | 668 | 683 | 937 |
| Research and development | 36,565 | 40,169 | 32,975 | 37,865 |
| General and administrative | 8,084 | 6,666 | 5,542 | 7,419 |
| Total operating expenses | 44,649 | 46,835 | 38,517 | 45,284 |
| Loss from operations | -43,615 | -46,167 | -37,834 | -44,347 |
| Change in fair value of preferred stock tranche right liability | - | 0* | 0 | 0 |
| Interest income | 3,054 | 3,654 | 4,105 | 4,431 |
| Other expense, net | -30 | 54* | -19 | -50 |
| Total other income, net | 3,024 | 3,708 | 4,086 | 4,381 |
| Net loss | -40,591 | -42,459 | -33,748 | -39,966 |
| Redeemable convertible preferred stock cumulative dividends | - | 0 | 0 | 0 |
| Net loss attributable to common stockholders | - | -42,459 | -33,748 | -39,966 |
| Basic EPS | -0.75 | -0.785 | -0.63 | -0.74 |
| Diluted EPS | -0.75 | -0.785 | -0.63 | -0.74 |
| Basic Average Shares | 54,332,319 | 54,091,471 | 53,930,946 | 53,770,868 |
| Diluted Average Shares | 54,332,319 | 54,091,471 | 53,930,946 | 53,770,868 |
Upstream Bio, Inc. (UPB)
Upstream Bio, Inc. (UPB)